Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

SOUTHERN IDAHO HEALTH PARTNERS LLC

NPI: 1952701401 · MERIDIAN, ID 83642 · General Practice Physician · NPI assigned 09/02/2014

$9.21M
Total Medicaid Paid
168,434
Total Claims
165,269
Beneficiaries
89
Codes Billed
2018-01
First Month
2024-03
Last Month

Provider Details

Authorized OfficialNEAL, GINA (CREDENTIALING)
NPI Enumeration Date09/02/2014

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 12,421 $594K
2019 18,589 $1.06M
2020 31,189 $1.54M
2021 36,001 $1.91M
2022 38,858 $2.18M
2023 26,682 $1.63M
2024 4,694 $296K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 53,643 52,227 $3.18M
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 31,052 30,078 $2.42M
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) 4,224 4,220 $423K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) 3,921 3,918 $398K
95810 Polysomnography; sleep staging with 4 or more additional parameters 850 839 $349K
99203 Office or other outpatient visit for the evaluation and management of a new patient, low complexity 4,604 4,556 $346K
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) 3,295 3,148 $292K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 14,165 14,088 $249K
99204 Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 1,940 1,929 $228K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) 1,695 1,695 $187K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 2,384 2,342 $156K
90472 Immunization administration, each additional vaccine (list separately) 7,067 7,050 $152K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 3,719 3,662 $147K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 4,173 4,149 $130K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 967 964 $83K
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward 1,255 1,247 $65K
92012 Ophthalmological services: medical examination and evaluation, intermediate, established patient 1,298 1,223 $58K
92014 Ophthalmological services: medical examination and evaluation, comprehensive, established patient 720 712 $52K
42820 Tonsillectomy and adenoidectomy; younger than age 12 209 209 $48K
95811 87 87 $32K
90473 994 994 $17K
96110 Developmental screening, with scoring and documentation, per standardized instrument 2,235 2,233 $15K
99201 397 395 $14K
99173 1,841 1,840 $12K
92004 Ophthalmological services: medical examination and evaluation, comprehensive, new patient 119 116 $12K
90474 1,011 1,011 $12K
0012A 348 345 $12K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 739 718 $11K
99234 104 98 $10K
96127 2,092 2,064 $9K
0011A 308 304 $9K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 570 570 $8K
99215 Prolong outpt/office vis 69 66 $8K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 172 172 $7K
69210 295 288 $7K
90962 210 189 $7K
69436 Tympanostomy (requiring insertion of ventilating tube), general anesthesia 40 40 $5K
0071A 132 131 $5K
0072A 104 104 $4K
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring 13 13 $4K
0002A 88 88 $4K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 27 26 $3K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited 50 40 $3K
90686 4,795 4,786 $3K
90480 68 67 $3K
0001A 64 64 $3K
99205 Prolong outpt/office vis 13 13 $2K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation 13 13 $1K
81002 348 342 $946.75
36415 Collection of venous blood by venipuncture 266 266 $699.09
59025 Fetal non-stress test 26 25 $632.35
99177 200 200 $579.08
0124A 12 12 $400.00
73630 28 25 $351.38
71046 Radiologic examination, chest; 2 views 26 26 $338.56
85610 70 51 $153.30
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 16 14 $144.58
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 12 12 $125.22
93010 Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only 19 19 $120.19
90672 1,266 1,265 $68.15
94760 31 29 $64.08
90648 1,869 1,867 $11.90
J1100 Injection, dexamethasone sodium phosphate, 1 mg 14 14 $9.02
3725F 70 67 $4.44
1031F 12 12 $3.19
90633 251 251 $0.01
90670 1,796 1,796 $0.00
1159F 189 180 $0.00
3078F 203 193 $0.00
1160F 103 99 $0.00
90700 12 12 $0.00
0502F 67 59 $0.00
90734 24 24 $0.00
90677 38 38 $0.00
90723 986 986 $0.00
90680 798 798 $0.00
90651 172 172 $0.00
90656 162 162 $0.00
3008F 271 254 $0.00
91301 430 422 $0.00
1126F 24 24 $0.00
1036F 101 91 $0.00
4010F 47 42 $0.00
3074F 207 201 $0.00
90688 12 12 $0.00
90674 26 25 $0.00
1170F 24 24 $0.00
Q2036 Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval) 15 15 $0.00
J8540 Dexamethasone, oral, 0.25 mg 12 12 $0.00